Navigation Links
LS9, Inc. Appoints Bill Haywood Chief Executive Officer
Date:10/8/2008

SOUTH SAN FRANCISCO, Calif., Oct. 8 /PRNewswire/ -- LS9, Inc., the Renewable Petroleum Company(TM), today announces it has appointed Bill Haywood as Chief Executive Officer. Mr. Haywood brings over 30 years of experience in the fuels manufacturing business and a proven track record of planning, engineering, execution and start-up of major projects within the energy sector.

"The coming year will be pivotal to LS9 as the company delivers significant achievements in the development of second-generation biofuels," said Noubar Afeyan, Managing Partner of Flagship Ventures and Chairman of the LS9 Board of Directors. "Bill brings with him the ideal combination of project development, organizational optimization and investment management expertise the company needs as it transitions from development to production. His extensive relationships in the transportation fuels sector and his deep understanding of strategic partnerships are an ideal complement to the talented scientific team at LS9. The Board is extremely pleased to have Bill at the helm of the company."

Prior to joining LS9, Mr. Haywood served as Senior Vice President of Refining for Tesoro Petroleum, where he was responsible for seven refineries and over $20 billion in revenue. Under his leadership, Tesoro became a leading independent refiner by integrating refinery acquisitions, driving operational excellence and building over $1 billion in capital projects. During this period, shareholder value increased by more than 86%.

"I can't think of a more exciting opportunity than joining LS9 as we prepare to move this important technology to commercial production and become the first advanced biofuels company to reach the market," said Mr. Haywood. "I look forward to merging knowledge of the traditional transportation fuels business with synthetic biology to help bring LS9's renewable fuels and chemicals into the pipeline and to the consumer."

About LS9

LS9, Inc., the Renewable Petroleum Company(TM), is a privately-held industrial biotechnology company pursuing the commercial development of renewable fuels and chemicals. LS9 is applying synthetic biology to produce proprietary biofuels that are compatible with existing fuel distribution and consumer infrastructure and high value industrial chemicals. LS9 is the pioneer in the commercial development of fermentation derived hydrocarbon biofuels and its patent-pending Renewable Petroleum(TM) products are custom engineered in the lab to address immediate market needs for clean energy alternatives to petroleum. The company was founded in 2005 and venture capital firms Flagship Ventures, Khosla Ventures, and Lightspeed Venture Partners have provided funding to date. LS9 is headquartered in South San Francisco, California.


'/>"/>
SOURCE LS9, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
2. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
3. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
4. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
5. ACORN Contract Research Organization Appoints Tara Webb as Senior Director of CRO Business Development
6. Neurofocus Appoints Stephen Kosslyn to Its Advisory Board
7. Cytochroma appoints Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance
8. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
9. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
10. China Yingxia International, Inc. Appoints New Vice President of Finance
11. SoluBest Appoints Michael Sheckler, MBA, as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... animal blood plasma products and derivatives market is fragmented due to the ... large players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, ... clear leader, these three companies, collectively, held more than 76% of ... ...
(Date:3/22/2017)... ... 2017 , ... Researchers face a fundamental challenge as they ... tissues, bones, even whole organs to implant in people to treat disease or ... the developing tissue. , Current bioengineering techniques, including 3-D printing, can’t fabricate ...
(Date:3/22/2017)... , March 22, 2017   iSpecimen ®, ... that Doctors Pathology Service (DPS), a full-service ... the United States , has joined ... Health Information Network (DHIN) to make human biospecimens ... The novel program, announced in 2015 as a ...
(Date:3/22/2017)... Pa. , March 22, 2017 /PRNewswire/ ... global independent provider of product and service ... today that it has acquired EPL Archives, ... supports customers across the entire regulated product ... archive sample, document storage and ancillary services. ...
Breaking Biology Technology:
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , ... software globally, announces significant enhancements to new and core ... 2016. New products include mobile and desktop Acuant FRM ... TM - a real time manual review of ... idScan® technology provides the fastest and most accurate capture ...
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
Breaking Biology News(10 mins):